Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Colonic hepatic tumor overexpressed gene (ch-TOG), a member of the highly conserved
XMAP215
family of microtubule-associated proteins (MAPs), plays a crucial role in bipolar mitotic spindle assembly. Here, we performed proof-of-principle studies targeting ch-
TOG
for the development of
HCC
and further compared its prognostic significance with the clinicopathologic features of
HCC
. Quantitative real-time PCR was used to measure the expression level of ch-
TOG
mRNA in 207 cases of paired
HCC
and adjacent noncancerous liver tissues (ANLT). Additionally, immunohistochemistry was employed to identify ch-
TOG protein
in 71
HCC
tissues. All
HCC
patients were divided into two groups according to the expression level of ch-
TOG
. Cumulative progression-free survival (PFS) and overall survival (OS) curves were estimated using the Kaplan-Meier method, and the prognostic value of ch-
TOG
was further evaluated using the Cox proportional hazards regression model. Our studies suggested that ch-
TOG
is overexpressed in
HCC
tissues compared with ANLT. The ch-
TOG
level was correlated with other prognostic factors, including the hepatitis B surface antigen (HBsAg) (p = 0.030), median size (p = 0.008), clinical tumor-node-metastasis (TNM) stage (p = 0.002), and alpha-fetoprotein (AFP) level (p = 0.030). Kaplan-Meier survival analysis showed that increased ch-
TOG
was associated with reduced PFS (p = 0.002) and OS (p = 0.004). Multivariate Cox proportional hazards analysis identified ch-
TOG
as an independent prognostic factor for the PFS (hazard ratio [HR] = 1.479, 95% confidence interval [CI] = 1.028-2.127, p = 0.035) and OS (HR = 1.609, 95% CI = 1.114-2.325, p = 0.011) of the
HCC
patients. Increased ch-
TOG
represents a powerful marker for predicting poorer prognosis in the clinical management of
HCC
, and may serve as a potential molecular target for
HCC
therapies in the future.
...
PMID:Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma. 2715 45